|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 27, 2016 ) Publisher's, 'Guillain-Barre Syndrome - Pipeline Review, H1 2016', provides an overview of the Guillain-Barre Syndrome pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Guillain-Barre Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Guillain-Barre Syndrome and features dormant and discontinued projects.
Publisher's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Other Key Points in Report:
- The report provides a snapshot of the global therapeutic landscape of Guillain-Barre Syndrome
- The report reviews pipeline therapeutics for Guillain-Barre Syndrome by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Guillain-Barre Syndrome therapeutics and enlists all their major and minor projects
- The report assesses Guillain-Barre Syndrome therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Guillain-Barre Syndrome
Ask for Sample Report @ http://www.reportsweb.com/inquiry&RW0001242078/sample
Table of Content: An Overview
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Guillain-Barre Syndrome Overview 6
Therapeutics Development 7
Pipeline Products for Guillain-Barre Syndrome - Overview 7
Pipeline Products for Guillain-Barre Syndrome - Comparative Analysis 8
Guillain-Barre Syndrome - Therapeutics under Development by Companies 9
Guillain-Barre Syndrome - Therapeutics under Investigation by Universities/Institutes 10
Guillain-Barre Syndrome - Pipeline Products Glance 11
Late Stage Products 11
Clinical Stage Products 12
Early Stage Products 13
Guillain-Barre Syndrome - Products under Development by Companies 14
Guillain-Barre Syndrome - Products under Investigation by Universities/Institutes 15
Guillain-Barre Syndrome - Companies Involved in Therapeutics Development 16
Akari Therapeutics, Plc 16
Alexion Pharmaceuticals, Inc. 17
Regenesance BV 18
Takeda Pharmaceutical Company Limited 19
Guillain-Barre Syndrome - Therapeutics Assessment 20
Assessment by Monotherapy Products 20
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001242078/discount
Assessment by Target 21
Assessment by Mechanism of Action 23
Assessment by Route of Administration 25
Assessment by Molecule Type 27
Drug Profiles 29
Coversin - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
eculizumab - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
immune globulin (human) - Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
immune globulin (human) - Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
Peptide for Cholera and Guillain-Barre Syndrome - Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001242078/buy/2000
About Us:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us:
Email: sales@reportsweb.com
Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
